Gene Therapy Shows Promise for Cutting LDL in Half in Tough-to-Treat Dyslipidemia

(MedPage Today) — NEW ORLEANS – A single injection of a gene-edited protein was deemed productive and safe in patients with dyslipidemia that was unresponsive to lipid-lowering therapy, according to a phase I trial.
IV CTX310 is an in vivo…

Source link : https://www.medpagetoday.com/meetingcoverage/aha/118389

Author :

Publish date : 2025-11-08 16:38:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Gene Therapy Shows Promise for Cutting LDL in Half in Tough-to-Treat Dyslipidemia

Navigating the Skin-Related Variants of Lupus

I’m a Dietitian. The Push for More Nutrition Education Is Spot On.

Related Posts

I’m a Dietitian. The Push for More Nutrition Education Is Spot On.

Navigating the Skin-Related Variants of Lupus

Meta-Analyses Argue for Broader Use of SGLT2 Inhibitors in Chronic Kidney Disease

Disease of 1,000 Faces Shows How Science Is Tackling Immunity’s Dark Side

Novel GLP-1 Drug on Attack Path Against Very High Triglycerides

GLP-1 Use Prior to Pregnancy Tied to Lower Gestational Diabetes Risk

I’m a Dietitian. The Push for More Nutrition Education Is Spot On.

Gene Therapy Shows Promise for Cutting LDL in Half in Tough-to-Treat Dyslipidemia

Navigating the Skin-Related Variants of Lupus

Meta-Analyses Argue for Broader Use of SGLT2 Inhibitors in Chronic Kidney Disease

Disease of 1,000 Faces Shows How Science Is Tackling Immunity’s Dark Side

Novel GLP-1 Drug on Attack Path Against Very High Triglycerides

GLP-1 Use Prior to Pregnancy Tied to Lower Gestational Diabetes Risk

Artificial Light at Night May Raise CVD Risk

Categories

Archives